NEW YORK (GenomeWeb News) – The Camden, NJ-based Coriell Institute for Medical Research today said that it has partnered with Cooper University Hospital as part of the recently established Delaware Valley Personalized Medicine Project.
The DVPMP was established in December 2007 with a goal of genotyping up to 100,000 patient volunteers for studies of the use of genetic risk factors in patient care. At the time of its launch, Coriell said the DVPMP would enroll 10,000 participants for the project over the next three years and eventually plans to reach 100,000 participants.
Under the partnership with Cooper, which is the core clinical campus for the Robert Wood Johnson Medical School in Camden, the collaborators intend to enroll 2,000 Cooper employees and their families in the project.
"This is an exciting opportunity for our employees to participate in the advancement of medicine and simultaneously receive valuable personal genetic information that can improve their health and prolong their lives," John Sheridan, president and CEO of Cooper, said in a statement.
In addition to Cooper, other partners in the DVPMP include the Fox Chase Cancer Center, Cooper University Hospital, and Virtua Health.